Most troublesome quality of life concerns in patients with brain metastases: baseline results from the phase III trial with motexafin gadolinium Article

Rodrigus, P, Mehta, MP, Dehnad, H et al. (2001). Most troublesome quality of life concerns in patients with brain metastases: baseline results from the phase III trial with motexafin gadolinium . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 51(3), 410. 10.1016/s0360-3016(01)02578-0

cited authors

  • Rodrigus, P; Mehta, MP; Dehnad, H; Rao, A; Suh, J; Roa, W; Souhami, L; Bezjak, A; Leibenhaut, M; Komaki, R; Schultz, CJ; Timmerman, R; Illidge, T; Curran, WJ; Phan, SC; Smith, J; Renschler, MF

authors

publication date

  • November 1, 2001

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • 410

volume

  • 51

issue

  • 3